Short Interest in HeartSciences Inc. (NASDAQ:HSCS) Expands By 125.2%

Posted by George Bondi on Sep 14th, 2026

HeartSciences Inc. (NASDAQ:HSCS – Get Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totaling 114,152 shares, a growth of 125.2% from the August 15th total of 50,682 shares. Currently, 3.1% of the company’s shares are sold short. Based on an average daily volume of 167,140 shares, the days-to-cover ratio is currently 0.7 days.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on HSCS shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of HeartSciences in a report on Wednesday, June 24th. Wall Street Zen upgraded shares of HeartSciences to a “sell” rating in a research note on Saturday. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $8.00.

Get Our Latest Stock Report on HeartSciences

HeartSciences Stock Performance

HSCS traded up $0.03 during trading on Monday, hitting $3.42. 42,756 shares of the stock were exchanged, compared to its average volume of 848,126. The firm has a 50 day simple moving average of $2.67 and a 200 day simple moving average of $2.38. The firm has a market cap of $13.33 million, a price-to-earnings ratio of -0.87 and a beta of 1.85. HeartSciences has a 1 year low of $1.63 and a 1 year high of $4.35.

HeartSciences (NASDAQ:HSCS – Get Free Report) last issued its earnings results on Thursday, July 23rd. The company reported ($0.88) earnings per share for the quarter, missing the consensus estimate of ($0.66) by ($0.22). As a group, equities analysts anticipate that HeartSciences will post -3.04 earnings per share for the current fiscal year.

Institutional Trading of HeartSciences

A hedge fund recently raised its position in HeartSciences stock. DRW Securities LLC raised its holdings in shares of HeartSciences Inc. (NASDAQ:HSCS – Free Report) by 13.7% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 95,065 shares of the company’s stock after purchasing an additional 11,455 shares during the period. DRW Securities LLC owned 2.99% of HeartSciences worth $294,000 at the end of the most recent reporting period. 17.24% of the stock is owned by institutional investors.

HeartSciences Company Profile

(Get Free Report)

HeartSciences, Inc (NASDAQ: HSCS) is a medical device company focused on the development and commercialization of advanced, non‐invasive cardiac diagnostic technologies. The company’s flagship product, MyoVista, is a high‐fidelity electrocardiograph (ECG) designed to detect subtle changes in cardiac function that may indicate myocardial ischemia or left ventricular dysfunction. By leveraging high‐frequency wavelet analysis within the QRS complex, MyoVista provides clinicians with enhanced visualization and analytical capabilities that extend beyond those of standard ECG systems.

HeartSciences supports the MyoVista system with an integrated software suite that automates data analysis and report generation, facilitating seamless integration into existing clinical workflows.